New York · Nonprofit
THE GLAUCOMA FOUNDATION INC
THE GLAUCOMA FOUNDATION INC (New York) receives grants from 103 organizations whose IRS filings report $4,530,641 to it, the largest being THE GERALD AND DAPHNA CRAMER FOUNDATION ($2,250,000). 49 of them have funded it in more than one year.
- Revenue FY2025
- $6.0M
- Funders on record
- 103
- Grants received
- $4.5M
- Net assets
- $19M
What The Glaucoma Foundation Inc does
Mission
The glaucoma foundation, inc. Is an international not-for-profit organization dedicated to eradicating glaucoma, the leading cause of preventable blindness. The strategy to achieve this goal is two-fold: raise public awareness concerning the necessity of routine eye exams, and fund critical research to find cures for glaucoma.
As stated on its FY2025 Form 990.
Programs
1) multiple webinars: what do cold hands have to do with glaucoma? The promise of optic nerve regeneration; the body-eye relationship how to save the sight of patients with glaucoma while minimizing adverse reaction from eye drops; insights into glaucoma & women's health: exploring the impact of menopause and visual function; glaucoma and lifestyle. 2) the optic nerve rescue and restoration think tank "a patient-centric approach while incorporating the latest science" glaucoma data integration: overview of databases available to advance glaucoma knowledge; lessons learned about glaucoma from the uk biobank; poag genomic architecture; a 360-degree biomedical profile of health: lessons from cardiovascular disease. 3) drug re-purposing in glaucoma: insulin signaling and; metformin and glaucoma; glp-1r agonists and glaucoma. 4) overview of glaucoma neuroprotection agents: why do we not have a neuroprotection agent for glaucoma? How can ai help facilitate randomized clinical trials in neuroprotection? 5) sex hormones and glaucoma: the role of sex hormones in the pathogenesis of open-angle glaucoma: evidence from epidemiological studies; estrogen signaling pathways in glaucoma; the…
$865,695 spent36% of program spending1) genetic predisposition and ophthalmic outcomes; 2) optic nerve regeneration; 3) using artificial intelligence to reveal blood pressure's role in glaucoma progression; 4) ee-purposing an "old" drug for a new indication: elucidating the peripheral and central effects of glucagon-like peptide 1 receptor agonists to treat glaucoma; 5) search for functional loxl1 risk alleles with bit-starr; 6) vascular genotype-phenotype association in primary open-angle glaucoma; 7) investigating the role of impaired mitochondrial dynamics in exfoliation glaucoma; 8) uncovering the potential of pericytes as therapeutic targets for glaucoma; 9) nicotinamide and pyruvate for neuroenhancement in open-angle glaucoma: a phase 2 randomized clinical trial.
$1,509,236 spentof which $982,807 as grants64% of program spending
The 2 programs described on its FY2025 Form 990, listed largest first by expense. Program spending in total: $2,374,931.
The organization over time
Each line starts at 100 in 2017, so what you read is the shape rather than the size: 150 means half as much again as 2017, 50 means half. The number beside each label in the key is where it ended. The shaded band is where the middle 50% of its peers' revenue would sit, given their growth.
Balance sheet
Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2023 to 2024, from $14M to $18M (+26%).
How it's funded, over time
Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.
85% of THE GLAUCOMA FOUNDATION INC’s revenue is contributions — more donation-reliant than the typical peer (51% for the typical peer).
Surplus & reserves
Operating surplus or deficit each year, and months of liquidity in hand. 2 of the last 9 reported years ran a deficit.
reserve
Leadership and staff
The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.
Who funds it, year by year
2017 → 2023: the base broadened from 17 funders to 35 funders, grant income rose $328k → $518k.
7 of 103 of your funders are donor-advised or pass-through sponsors (tagged DAF) — 25% of grant dollars received. That money is really individual donors directing a sponsor; the institutions to cultivate are the non-DAF funders.
From the IRS filings of THE GLAUCOMA FOUNDATION INC’s funders (the co-funder graph). Top 30 of 103 funders by total. Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
How concentrated its funding is
THE GLAUCOMA FOUNDATION INC leans on a few funders — its largest provides 50% of grant income and the top three 79%; half comes from just 2 funders.
the vertical line marks half of all grant income — 2 funders to its left
29% of the income these shares are computed over arrives through pass-through sponsors or from payers whose filings do not say what kind of payment it is. Concentration is still measured over all of it, because the money is real; what it does not support is a claim about how many institutions have chosen to fund THE GLAUCOMA FOUNDATION INC.
Largest funder’s share by year: 2017 76% · 2018 46% · 2019 91% · 2020 62% · 2021 50% · 2022 61% · 2023 58% — diversifying over time.
“Effective funders” = inverse Herfindahl index (1 / Σ shareᵢ²) — the number of equal-sized funders that would give the same concentration. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
How long its funders stay
42% of THE GLAUCOMA FOUNDATION INC's funders are still giving 3 years after their first grant; 48% give in more than one year at all.
Share of funders still giving k years after their first recorded grant, pooled across every acquisition cohort. A funder counts as retained in a year only if it made a grant that year. Measured to FY2023, the last fiscal year that has finished arriving — a funder cannot be counted as lapsed in a year most filers have not reached.
Where its funders are
80% of THE GLAUCOMA FOUNDATION INC's grant income comes from New York funders.
In-state vs out-of-state, by year
Funder states come from each funder’s own filing. $1.1M arriving through sponsors registered in 7 states is excluded from the map and the split above: a sponsor holds money on a donor’s behalf, so its registered address would place those dollars somewhere no donor need ever have been. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Against its field
THE GLAUCOMA FOUNDATION INC runs a healthier operating margin than three-quarters of the 5,002 health nonprofits its size.
this organization peer median middle 50% of peers· 5,002 health nonprofits $1M–$10M, FY2025
Organizations like THE GLAUCOMA FOUNDATION INC
Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.
In New York
Nationally
Read directly from this organization’s own Form 990, as neutral context.
Where the money goes
78% of spending goes to programs.
Governance
Public support
62%
Share of support from the public (Schedule A) — the basis for its public-charity status.
Footprint & structure
Files a return copy in 36 states
Screen this organization
A dated, signed PDF of the compliance screen for THE GLAUCOMA FOUNDATION INC: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.
Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf
Questions and answers
- Who funds THE GLAUCOMA FOUNDATION INC?
- THE GLAUCOMA FOUNDATION INC (New York) receives grants from 103 organizations whose IRS filings report $4,530,641 to it, the largest being THE GERALD AND DAPHNA CRAMER FOUNDATION ($2,250,000). 49 of them have funded it in more than one year.
- How many funders does THE GLAUCOMA FOUNDATION INC have?
- IRS filings report 103 organizations giving $4,530,641 in grants to THE GLAUCOMA FOUNDATION INC, 49 of which have funded it in more than one year.
- Who is the largest funder of THE GLAUCOMA FOUNDATION INC?
- THE GERALD AND DAPHNA CRAMER FOUNDATION is the largest funder on record, with $2,250,000 in grants. The full list of funders is on this page.
- How can an organization like THE GLAUCOMA FOUNDATION INC find more funders?
- Start with the funders already giving here, then look at the foundations that back similar organizations in New York. The funding by cause and by state pages list the largest funders for a given area and how to approach them.
These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2025 (financials across 2017–2025), and the filings of 103 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 22, 2026. What this page cannot tell you · view filing